Amounts doctors used in past patient studies
Thymosin Alpha-1 Dosage: What Patients Received in Trials
The amount and timing changed with each illness. These study records don't provide a personal treatment plan.
Trials used different amounts for different illnesses
Doctors measured how patient groups responded to Thymosin Alpha-1. They usually injected the drug just beneath the skin. For viral liver disease, the most cited plan used 1.6 mg twice a week. Staff watched those patients and checked their blood.
Emergency studies gave shots more often but for fewer days. The drug soon leaves the blood, while changes it starts in white cells may last longer. An amount alone therefore cannot tell you whether a plan is safe for you. These figures describe past trials; they don't direct you to give yourself a shot.
Thymosin alpha 1 dosage ranged widely across trials
A large review found single shots from 0.8 to 6.4 mg. Short hospital courses used a total of 1.6-16 mg over five to seven days [4]. Longer liver studies most often put the drug under the skin two times a week [4].
One hepatitis B trial used 1.2 mg on its set schedule for 24 weeks [8]. Tα1 was given on planned trial days, rather than spread as one tiny amount across six months. Each figure belongs to one closely watched patient group. A clinician with your full health history must decide whether any treatment fits your care.
Thymosin alpha 1 injection plans followed the illness being treated
Patient trials gave Tα1 by injection just below the skin [5][9]. For severe blood poisoning, ETASS and TESTS used 1.6 mg every 12 hours [2][3]. This short course continued for five to seven days. Hospital COVID-19 work used 1.6 mg daily [6].
Cancer studies paired chemotherapy with 1.6 mg twice weekly [7]. The drug arrived as a dry powder, and staff added germ-free water under clean conditions. Blood and tissue then broke it down quickly [4]. Your safety in these studies depended partly on trained staff handling the mixing and timing.
Long-term liver trials and short emergency trials used different plans
Liver disease studies spread shots across several months. They used 1.6 mg twice a week, or 1.2 mg on a set plan for 24 weeks in hepatitis B [4][8]. The second figure isn't the total for all six months. It is the amount listed each time the plan called for it.
Sepsis trials used 1.6 mg every 12 hours for five to seven days [2][3]. A pancreatitis trial used 3.2 mg twice a day for seven days. COVID-19 units used 1.6 mg daily [6], while cancer work kept weekly injections going for as long as twelve months. Trained staff watched every patient in these studies [4].
Half the drug leaves the blood after only a few hours
Following an injection just beneath the skin, the amount in your blood falls quickly. Its half-life is about 2 hours, so half the drug is gone by then [4]. Your blood level peaks within 1-2 hours. By 24 hours, it is nearly back where it started.
Tα1 has a small chemical cover that slows its early breakdown. Blood and tissue break the drug apart after it reaches white blood cells. Any longer effect comes from changes begun in those cells, not from drug staying in your blood [5]. Thus “half gone” early and “nearly back” by day's end can both be true for you.
Clinic staff mixed the dry powder with germ-free water
Hospitals received the drug as a freeze-dried powder in sealed glass vials [4]. A nurse or druggist added germ-free water before giving the shot. Poor mixing or a dirty vial can bring germs under the skin. Blood then breaks the drug apart soon after the shot.
Medical papers list single shots from 0.8 to 6.4 mg because doctors studied many illnesses [4]. The 1.6 milligram twice-a-week plan appears most often in viral liver studies. That was a plan used abroad under medical care. The need for clean mixing is one reason these figures aren't instructions for home use.
The trial amounts aren't a personal treatment guide
Thymosin Alpha-1 has never received FDA approval in this country [4]. No approved home dose or schedule exists. Trial doctors watched liver tests, virus levels, and white blood cell counts. That close care was part of what protected each patient.
Online vials don't pass through the same drug checks [4]. Their powder could be too strong, carry germs, or contain no real medicine. A hospital paper cannot make an unchecked product safe for you. Your doctor can discuss proven choices that suit your illnesses and medicines.